NASDAQ: NKTR NEKTAR THERAPEUTICS 8-K

Nektar shareholders approve 3M share equity plan expansion at annual meeting

Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

  • medium

    Shareholders approved adding 3 million shares to the employee equity compensation plan, expanding the pool for stock-based awards. The vote passed with 73% support despite meaningful opposition.

    Item 5.07: Annual Meeting Results verify on EDGAR →
  • low

    Howard W. Robin elected to board with 72% support to serve until 2029 annual meeting. Five other directors continue their current terms.

    Item 5.07: Director Election verify on EDGAR →
  • low

    Ernst & Young ratified as independent auditor for 2026 with 99% approval. Executive compensation plan received 99% advisory approval in non-binding say-on-pay vote.

    Item 5.07: Auditor & Compensation verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade NKTR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 5:06 AM